Low-Colony Counts of Nontuberculous Mycobacteria: Clinical Significance Analysis.
- Author:
Ki Ho HONG
1
;
Se Ick JOO
;
Eui Chong KIM
;
Sue SHIN
;
Eun Youn ROH
;
Jong Hyun YOON
Author Information
- Publication Type:Original Article
- Keywords: Nontuberculous mycobacteria; Low-colony count; Lung diseases
- MeSH: Biological Science Disciplines; Chimera; Follow-Up Studies; Humans; Lung Diseases; Medical Records; Nontuberculous Mycobacteria; Oligonucleotide Array Sequence Analysis; Prevalence
- From:Korean Journal of Clinical Microbiology 2012;15(1):9-13
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: Diagnosis of nontuberculous mycobacterium (NTM) is challenging, and clinical, radiological and microbiological criteria should be met. Traditionally, culture results on solid media have been reported semi-quantitatively, but no study exists regarding the clinical significance of low-colony count culture reports. The authors of the present study analyzed the clinical significance of low-colony count specimens of NTM with a greater than three-year follow-up period. METHODS: A total of 341 clinical isolates were evaluated among the isolates at Seoul National University Hospital and Seoul National University Borame Hospital from October 2005 to September 2006. Colony count less than 50 was considered a low-colony count specimen. Identifications of NTM from all the isolates were performed using a DNA chip (PCR reverse hybridization, LG Life Science, Korea). Clinical significance was analyzed by reviewing the medical records of patients with greater than three years of follow-up data after NTM isolation from respiratory samples. RESULTS: NTM lung disease was observed in 27.0% of the patients with low-colony count specimens among 167 patients with respiratory samples, and 70.4% of the patients were treated. The low-colony count patients had less NTM lung disease, longer incubation period, and less acid fast bacilli-positivity than patients with a colony count greater than 50. CONCLUSION: The prevalence of NTM lung disease with a low-colony count specimen was greater than 25%. In a clinical setting, NTM lung disease should not be excluded only on the basis of a low-colony count.
